Ming-Jai Su Selected Research

Ming-Jai Su Research Topics

Disease

10	Ischemia 01/2016 - 04/2002
10	Infarction (Infarctions) 05/2015 - 04/2002
9	Reperfusion Injury 05/2015 - 04/2002
6	Fibrosis (Cirrhosis) 01/2020 - 02/2014
5	Endotoxemia 12/2019 - 03/2006
5	Myocardial Ischemia (Ischemic Heart Diseases) 05/2015 - 03/2004
4	Myocardial Infarction 06/2014 - 12/2004
4	Atrial Fibrillation 01/2006 - 02/2003
3	Ventricular Tachycardia 01/2017 - 03/2003
3	Coronary Disease (Coronary Heart Disease) 03/2015 - 04/2002
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2014 - 10/2006
3	Cardiac Arrhythmias (Arrythmia) 07/2008 - 06/2003
3	Wounds and Injuries (Trauma) 05/2007 - 04/2002
2	Leukemia 01/2020 - 01/2012
2	Sepsis (Septicemia) 12/2019 - 03/2006
2	Heart Diseases (Heart Disease) 06/2018 - 12/2016
2	Chronic Renal Insufficiency 01/2017 - 07/2015
2	Heart Failure 09/2015 - 02/2008
2	Inflammation (Inflammations) 03/2015 - 05/2007
2	Necrosis 08/2013 - 01/2005
2	Type 2 Diabetes Mellitus (MODY) 06/2013 - 10/2006
2	Hypertension (High Blood Pressure) 01/2012 - 02/2003
2	Shock 12/2010 - 01/2005
2	Septic Shock (Toxic Shock Syndrome) 12/2010 - 03/2006
2	Hypotension (Low Blood Pressure) 03/2006 - 01/2005
2	Ventricular Fibrillation 01/2006 - 05/2003
1	Atrial Remodeling 01/2017
1	Hyperaldosteronism (Conn Syndrome) 01/2016
1	Hypertrophy 09/2015
1	Adenoma (Adenomas) 09/2015
1	Essential Hypertension 09/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Cardio-Renal Syndrome 07/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Ureteral Obstruction 03/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2014
1	ST Elevation Myocardial Infarction 03/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2014
1	Diastolic Heart Failure 02/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2004
5	AntioxidantsIBA 01/2016 - 04/2002
4	caffeic acidIBA 09/2015 - 01/2012
4	Streptozocin (Streptozotocin)FDA Link 06/2014 - 10/2006
4	thaliporphineIBA 12/2010 - 01/2005
3	oxidized low density lipoproteinIBA 01/2017 - 03/2014
3	CalciumIBA 07/2015 - 05/2003
3	KS370GIBA 03/2015 - 06/2012
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2014 - 12/2010
3	Hypoglycemic Agents (Hypoglycemics)IBA 06/2013 - 10/2006
3	CholesterolIBA 05/2007 - 05/2003
3	ResveratrolIBA 01/2007 - 04/2002
2	Rho Guanine Nucleotide Exchange FactorsIBA 01/2020 - 01/2012
2	CytokinesIBA 12/2019 - 03/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2019 - 12/2004
2	AldosteroneIBA 01/2016 - 09/2015
2	Free RadicalsIBA 01/2016 - 04/2002
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 06/2012
2	caffeic acid phenethyl esterIBA 03/2015 - 06/2014
2	CollagenIBA 03/2015 - 07/2014
2	Fibronectins (Fibronectin)IBA 03/2015 - 07/2014
2	AmidesIBA 07/2014 - 01/2012
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2014 - 03/2004
2	EndotoxinsIBA 12/2010 - 01/2005
2	3,3',4,5'-tetrahydroxystilbeneIBA 06/2009 - 04/2002
2	Doxazosin (Cardura)FDA LinkGeneric 07/2008 - 03/2008
2	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2008 - 03/2008
2	bunazosin (Andante)IBA 07/2008 - 03/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2006 - 03/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006 - 01/2005
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Anti-Arrhythmia AgentsIBA 12/2019
1	Toll-Like Receptor 4IBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	NF-kappa B (NF-kB)IBA 12/2019
1	IsoquinolinesIBA 12/2019
1	isoquinolineIBA 12/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2019
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 06/2018
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 09/2015
1	CatecholaminesIBA 09/2015
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2015
1	Lipoproteins (Lipoprotein)IBA 07/2015
1	1,10- dimethoxy- 6- (2- (2- methoxyphenoxy)ethyl)- 5,6,6a,7- tetrahydro- 4H- dibenzol(de,g)quinoline- 2,9- diy1 bis(dihydrogen phosphate)IBA 05/2015
1	salicylhydroxamic acid (SHAM)IBA 05/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2015
1	Metformin (Glucophage)FDA LinkGeneric 03/2015
1	Collagen Type I (Type I Collagen)IBA 03/2015
1	VimentinIBA 03/2015
1	EsterasesIBA 03/2015
1	Cadherins (E-Cadherin)IBA 07/2014
1	Plasminogen Activator Inhibitor 1IBA 07/2014
1	caffeic acid phenethyl amideIBA 06/2014
1	arginine methyl esterIBA 06/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2014
1	Connective Tissue Growth FactorIBA 02/2014

Therapy/Procedure

5	Therapeutics 12/2016 - 07/2004
1	Injections 09/2015
1	Adrenalectomy 09/2015
1	Intravenous Injections 06/2014